Stefan K. Alig

1 article listing Stefan K. Alig in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial Nature Communications